Prospective follow-up studies found no chromosomal mutagenicity of methylphenidate therapy in ADHD affected children

Toxicology Letters

Volumn 193, Issue 1, 2010, Pages 4-8

  Walitza, Susanne ^a,c   Kämpf, Kristina ^b   Gnana Oli, Rajaraman ^b   Warnke, Andreas ^c   Gerlach, Manfred ^c   Stopper, Helga ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Psychosomatics and Psychotherapy ^*  (Germany)

Author keywords

ADHD; Cytogenetic effects; Methylphenidate; Micronuclei; Psychostimulants

Indexed keywords

8 HYDROXYGUANINE; METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; CANCER RISK; CHILD CARE; CHROMOSOME ABERRATION; CHRONIC DRUG ADMINISTRATION; CYTOGENETICS; DNA DAMAGE; DRUG CARCINOGENICITY; FOLLOW UP; GENE MUTATION; GENOTOXICITY; HUMAN; LONG TERM CARE; MICRONUCLEUS; MUTAGENICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SISTER CHROMATID EXCHANGE;

ANIMALIA;

EID: 75949119835     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.12.013     Document Type: Note

References (30)

1. Biederman J., and Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 366 (2005) 237-248
2. Bonassi S., Znaor A., Ceppi M., Lando C., Chang W.P., Holland N., Kirsch-Volders M., Zeiger E., Ban S., Barale R., Bigatti M.P., Bolognesi C., Cebulska-Wasilewska A., Fabianova E., Fucic A., Hagmar L., Joksic G., Martelli A., Migliore L., Mirkova E., Scarfi M.R., Zijno A., Norppa H.M., and Fenech M. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28 (2007) 625-631
3. Bonassi S., Norppa H., Ceppi M., Strömberg U., Vermeulen R., Znaor A., Cebulska-Wasilewska A., Fabianova E., Fucic A., Gundy S., Hansteen I.L., Knudsen L.E., Lazutka J., Rossner P., Sram R.J., and Boffetta P. Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries. Carcinogenesis 29 (2008) 1178-1183
4. Brink A., Lutz U., Völkel W., and Lutz W.K. Simultaneous determination of O(6)-methyl-2-deoxyguanosine, 8-oxo-7,8-dihydro-2-deoxyguanosine, and 1,N(6)-etheno-2-deoxyadenosine in DNA using on-line sample preparation by HPLC column switching coupled to ESI-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 830 (2006) 255-261
5. Chao M.R., Yen C.C., and Hu C.W. Prevention of artifactual oxidation in determination of cellular 8-oxo-7,8-dihydro-2′-deoxyguanosine by isotope-dilution LC-MS/MS with automated solid-phase extraction. Free Radic. Biol. Med. 44 (2008) 464-473
6. Chovanová Z., Muchová J., Sivonová M., Dvoráková M., Zitnanová I., Waczulíková I., Trebatická J., Skodácek I., and Duracková Z. Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder. Free Radic. Res. 40 (2006) 1003-1010
7. Cooke M.S., Barregard L., Mistry V., Potdar N., Rozalski R., Gackowski D., Siomek A., Foksinski M., Svoboda P., Kasai H., Konje J.C., Sallsten G., Evans M.D., and Olinski R. Interlaboratory comparison of methodologies for the measurement of urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine. Biomarkers 14 (2009) 103-110
8. Dobrovolsky V.N., Boctor S.Y., Twaddle N.C., Doerge D.R., Bishop M.E., Manjanatha M.G., Kimoto T., Miura D., Heflich R.H., and Ferguson S.A. Flow cytometric detection of Pig-A mutant red blood cells using an erythroid-specific antibody: application of the method for evaluating the in vivo genotoxicity of methylphenidate in adolescent rats. Environ. Mol. Mutagen. (2009) (Epub ahead of print)
9. El-Zein R.A., Abdel-Rahman S.Z., Hay M.J., Lopez M.S., Bondy M.L., Morris D.L., and Legator M.S. Cytogenetic effects in children treated with methylphenidate. Cancer Lett. 230 (2005) 284-291
10. Holtmann M., Kaina B., and Poustka F. Methylphenidate-induced cytogenetic alterations?. Z. Kinder Jugendpsychiatr. Psychother. 34 (2006) 215-220
11. Jacobson-Kram D., Mattison D., Shelby M., Slikker W., Tice R., and Witt K. Methylphenidate and chromosome damage. Cancer Lett. 260 (2008) 216-218
12. Kratochvil C.J., Vaughan B.S., Barker A., Corr L., Wheeler A., and Madaan V. Review of pediatric attention deficit/hyperactivity disorder for the general psychiatrist. Psychiatr. Clin. North Am. 32 (2009) 39-56
13. Loft S., Høgh Danielsen P., Mikkelsen L., Risom L., Forchhammer L., and Møller P. Biomarkers of oxidative damage to DNA and repair. Biochem. Soc. Trans. 36 (2008) 1071-1076
14. Manjanatha M.G., Shelton S.D., Dobrovolsky V.N., Shaddock J.G., McGarrity L.G., Doerge D.R., Twaddle N.W., Lin C.J., Chen J.J., Mattison D.R., and Morris S.M. Pharmacokinetics, dose-range, and mutagenicity studies of methylphenidate hydrochloride in B6C3F1 mice. Environ. Mol. Mutagen. 49 (2008) 585-593
15. Manjanatha M.G., Shelton S.D., Dobrovolsky V.N., Shaddock J.G., McGarrity L.G., Twaddle N.W., Moore M.M., Mattison D.R., Slikker Jr. W., and Morris S.M. Evaluation of mutagenic mode of action in Big Blue mice fed methylphenidate for 24 weeks. Mutation (2009) (Epub ahead of print)
16. Martins M.R., Reinke A., Petronilho F.C., Gomes K.M., Dal-Pizzol F., and Quevedo J. Methylphenidate treatment induces oxidative stress in young rat brain. Brain Res. 1078 (2006) 189-197
17. Miura D., Dobrovolsky V.N., Kimoto T., Kasahara Y., and Heflich R.H. Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea. Mutat. Res. 677 (2009) 86-92
18. Morris S.M., Dobrovolsky V.N., Shaddock J.G., Mittelstaedt R.A., Bishop M.E., Manjanatha M.G., Shelton S.D., Doerge D.R., Twaddle N.C., Chen J.J., Lin C.J., Paule M.G., Slikker Jr. W., Hotchkiss C.E., Petibone D., Tucker J.D., and Mattison D.R. The genetic toxicology of methylphenidate hydrochloride in non-human primates. Mutat. Res. 673 (2009) 59-66
19. Murgia E., Ballardin M., Bonassi S., Rossi A.M., and Barale R. Validation of micronuclei frequency in peripheral blood lymphocytes as early cancer risk biomarker in a nested case-control study. Mutat. Res. 639 (2008) 27-34
20. Oestreicher N., Friedman G.D., Jiang S.F., Chan J., Quesenberry Jr. C., and Habel L.A. Methylphenidate use in children and risk of cancer at 18 sites: results of surveillance analyses. Pharmacoepidemiol. Drug Saf. 16 (2007) 1268-1272
21. Ponsa I., Ramos-Quiroga J.A., Ribasés M., Bosch R., Bielsa A., Ordeig M.T., Morell M., Miró R., de Cid R., Estivill X., Casas M., Bayés M., Cormand B., and Hervás A. Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate. Mutat. Res. 666 (2009) 44-49
22. Preston R.J., Kollins S.H., Swanson J.M., Greenhill L.L., Wigal T., Elliott G.R., and Vitiello B. Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al. Cancer Lett. 230 (2005) 292-294
23. Selby J.V., Friedman G.D., and Fireman B.H. Screening prescription drugs for possible carcinogenicity: 11 to 15 years of follow-up. Cancer Res. 49 (1989) 5736-5747
24. Stopper H., Walitza S., Warnke A., and Gerlach M. Brief review of available evidence concerning the potential induction of genomic damage by methylphenidate. J. Neural Transm. 115 (2008) 331-334
25. Suter W., Martus H.J., and Elhajouji A. Methylphenidate is not clastogenic in cultured human lymphocytes and in the mouse bone-marrow micronucleus test. Mutat. Res. 607 (2006) 153-159
26. Teo S.K., San R.H., Wagner V.O., Gudi R., Stirling D.I., Thomas S.D., and Khetani V.D. d-Methylphenidate is non-genotoxic in in vitro and in vivo assays. Mutat. Res. 537 (2003) 67-79
27. Tucker J.D., Suter W., Petibone D.M., Thomas R.A., Bailey N.L., Zhou Y., Zhao Y., Muniz R., and Kumar V. Cytogenetic assessment of methylphenidate treatment in pediatric patients treated for attention deficit hyperactivity disorder. Mutat. Res. 677 (2009) 53-58
28. Walitza S., Werner B., Romanos M., Warnke A., Gerlach M., and Stopper H. Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?. Environ. Health Perspect. 115 (2007) 936-940
29. Walitza S., Kämpf K., Artamonov N., Romanos M., Oli G.R., Wirth S., Warnke A., Gerlach M., and Stopper H. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy. Toxicol. Lett. 184 (2009) 38-43
30. Witt K.L., Shelby M.D., Itchon-Ramos N., Faircloth M., Kissling G.E., Chrisman A.K., Ravi H., Murli H., Mattison D.R., and Kollins S.H. Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD. J. Am. Acad. Child Adolesc. Psychiatry 47 (2008) 1375-1383